{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:55:59Z","timestamp":1774558559932,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ygyno.2012.12.026","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T17:05:22Z","timestamp":1356109522000},"page":"18-21","source":"Crossref","is-referenced-by-count":39,"title":["Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer"],"prefix":"10.1016","volume":"129","author":[{"given":"Kanokpis","family":"Townamchai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Damato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond","family":"O'Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2012.12.026_bb0005","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2012.12.026_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2012.12.026_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","article-title":"Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review","volume":"113","author":"Olawaiye","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ygyno.2012.12.026_bb0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2012.12.026_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2008.11.016","article-title":"Stage II uterine papillary serous carcinoma: carboplatin\/paclitaxel chemotherapy improves recurrence and survival outcomes","volume":"112","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2012.12.026_bb0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.09.005","article-title":"The importance of chemotherapy and radiation in uterine papillary serous carcinoma","volume":"123","author":"Viswanathan","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.12.026_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ygyno.2012.07.112","article-title":"Five-year outcomes of adjuvant carboplatin\/paclitaxel chemotherapy and intravaginal radiation for stage I\u2013II papillary serous endometrial cancer","volume":"127","author":"Kiess","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2012.12.026_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.12.026_bb0055","volume":"vol. 3","author":"Gallagher","year":"2012"},{"issue":"2","key":"10.1016\/j.ygyno.2012.12.026_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2008.07.019","article-title":"The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma","volume":"141","author":"Batchelor","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ygyno.2012.12.026_bb0065","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0360-3016(03)00753-3","article-title":"Outcome and pattern of failure in pathologic stage I\u2013II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy","volume":"57","author":"Mehta","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.ygyno.2012.12.026_bb0070","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2012.12.026_bb0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"9717","key":"10.1016\/j.ygyno.2012.12.026_bb0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2006.11.007","article-title":"Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches","volume":"105","author":"Barakat","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2008.10.006","article-title":"Concurrent carboplatin\/paclitaxel and intravaginal radiation in surgical stage I\u2013II serous endometrial cancer","volume":"112","author":"Alektiar","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.12.026_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","article-title":"The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer","volume":"85","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2012.12.026_bb0100","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2005.04.038","article-title":"American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy","volume":"63","author":"Small","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2012.12.026_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2012.07.111","article-title":"A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer","volume":"127","author":"Townamchai","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2012.12.026_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ygyno.2012.12.026_bb0120","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2012.12.026_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijrobp.2006.09.004","article-title":"Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma","volume":"67","author":"Fayed","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2012.12.026_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2004.05.009","article-title":"High-dose rate brachytherapy for stage I\/II papillary serous or clear cell endometrial cancer","volume":"94","author":"DuBeshter","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I\u2013II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2012.12.026_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2012.12.026_bb0145","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0360-3016(02)04404-8","article-title":"Outcome and patterns of failure in pathologic stages I\u2013IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy","volume":"55","author":"Murphy","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T13:00:57Z","timestamp":1562504457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812009742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090825812009742"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}